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Abstract: BANK1 is a susceptibility gene for several systemic autoimmune diseases in several populations.
Using the genome-wide association study (GWAS) data from Europeans (EUR) and African Americans
(AA), we performed an extensive fine mapping of ankyrin repeats 1 (BANK1). To increase the SNP
density, we used imputation followed by univariate and conditional analysis, combined with a haplotypic
and expression quantitative trait locus (eQTL) analysis. The data from Europeans showed that the
associated region was restricted to a minimal and dependent set of SNPs covering introns two and three,
and exon two. In AA, the signal found in the Europeans was split into two independent effects. All of
the major risk associated SNPs were eQTLs, and the risks were associated with an increased BANK1 gene
expression. Functional annotation analysis revealed the enrichment of repressive B cell epigenomic marks
(EZH2 and H3K27me3) and a strong enrichment of splice junctions. Furthermore, one eQTL located
in intron two, rs13106926, was found within the binding site for RUNX3, a transcriptional activator.
These results connect the local genome topography, chromatin structure, and the regulatory landscape of
BANK1 with co-transcriptional splicing of exon two. Our data defines a minimal set of risk associated
eQTLs predicted to be involved in the expression of BANK1 modulated through epigenetic regulation
and splicing. These findings allow us to suggest that the increased expression of BANK1 will have an
impact on B-cell mediated disease pathways.
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1. Introduction
The B cell adaptor with the ankyrin repeats 1 (BANK1) gene is a susceptibility gene for the systemic
autoimmune diseases of systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosis.
BANK1 is an adaptor molecule of 795aa in its full-length form (FL), and has two, less abundant
smaller isoforms, one of which lacks the second exon (D2) [1]. The protein is expressed primarily in
mature B cells and, to a lesser extent, in myeloid and plasmacytoid dendritic cells (pDCs). BANK1
protein has 23 tyrosines prone to phosphorylation, and it is extensively phosphorylated following the
B cell receptor cross-linking [2]. BANK1 was first identified as a partner of the tyrosine kinase LYN2,
and a knock-out mouse for BANK1 showed an increased CD40-dependent IgM production, germinal
center formation, and increased activation of Akt [3]. It was therefore suggested that BANK1 could
function as an inhibitor of B cell activation. It was recently shown that BANK1 shares, with other
molecules, the presence of a conformational toll/IL-1 receptor domain (TIR), and this domain is coded
by exon two; therefore, BANK1 could possibly play a role in toll-like receptor (TLR) signaling [4],
important for autoimmunity. Supporting such a role for BANK1, we showed that a deficiency of
BANK1 in the mouse leads to a reduction in the activity of the mitogen activation of proliferation kinase
(MAPK) p38, which specifically reduces the activation of the translation initiation complex eIF4E,
leading to a reduced production of IL-6, following stimulation with a TLR9 agonist (CpG) [5]. More
recently, we demonstrated that crosses between a lupus model and the BANK1−/− mice improve
several disease B cell phenotypes; primarily, there is a reduction in the production of the total IgG
and IgG anti-dsDNA antibodies, a reduction in serum IL-6 and BAFF, and reduced pSTAT1 signaling
at Tyrosine 701, following the TLR7-agonist stimulation. These data suggest a role for BANK1 in
the production of IgG dependent on STAT1. On the other hand, BANK1 has no direct role in IFN
JAK-STAT signaling, but instead, its signaling function is through TLR, reducing the expression of Ifnb
and Ifna2, as well as reducing the subsequent autocrine uptake by the IFN alpha receptor (IFNAR) in
the BANK1−/− mice [6]. Thus, the increased expression of the FL BANK1 isoform should increase the
risk for systemic lupus erythematosus (SLE). How the expression of BANK1 is regulated is presently
not known.
The genetic association with an autoimmune disease involved two polymorphisms, a branch point
site SNP (rs17266594), suggested to be involved in splicing efficiency and associated with increased
expression of the full-length isoform of BANK1, and a coding R61H variant identified through SNP
rs10516487 located in exon two. Both of the SNPs were in strong linkage disequilibrium. Only the
highly expressed full-length isoform contained the risk allele for BANK1 (R61) [1]. We later showed
R61H to have a potential effect in splicing and protein aggregation [7]. Using a minigene and a reporter
assay, we showed that the protective variant, encoding 61H, was not only influencing the protein
function, but that it also disturbed the splicing of exon two by creating a binding of the splicing protein
SRp40, therefore increasing the quantity of the D2 isoform of BANK1 and reducing that of the FL [7].
In order to determine, with precision, the location of the genetic association of BANK1, and to
investigate whether the SNPs within BANK1 could affect its expression, we performed a high-density
analysis of BANK1, through genotyping and imputation, combined with eQTL analyses using all of the
databases available, in a set of over 10,200 individuals of European and African American ancestries,
combined with ENCODE (Encyclopedia of DNA Elements) track analysis.
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2. Results
BANK1 Transethnic Finemapping
Using the high quality filtered genome-wide data from the European and African American
genome-wide association scans, we performed a univariate genetic logistic regression association
analysis of BANK1 using an additive model. In Europeans, 1133 imputed markers mapped on
BANK1 were tested for association. We selected a set of 307 markers with a p value lower than
0.05 (Supplemental Table S1A and Supplemental Figure S1A). Eighteen tagging markers captured
all 307 (100%) alleles at r2 ≥0.8, representing the 18 respective linkage disequilibrium groups
organized in four haplotypic blocks. Only one marker remained as an independent signal, rs17031708
(Figure 1, Table 1 and Supplemental Table S1A). The best hit for association was the SNP rs10028805,
(haplotypic block two, and linkage disequilibrium group five), with OR = 0.8177, confidence interval
(CI) = 95% (0.7656, 0.8735), and a Pcorr = 2.22E−09 (Figure 2a, Table 1, and Supplemental Table S1A).
Conditioning on rs10028805, the association disappeared, except that of the five low frequency
variants (MAF < 5%), rs148572654, rs10212686, rs62321740, 4:102857352:AT:ATT, and 4:102945562:GT:G
(Table 1 and Figure 2b), representing linkage groups 8, 11, 12, 16, and 19, respectively. Only by
conditioning on rs10028805 and three of these low frequency variants, namely, rs148572654, rs62321740,
and 4:102945562:GT:G, did all of the signals of association in BANK1 disappear (Table 1, Supplemental
Table S1A, and Figure 2c). In addition, these four markers constituted the haplotypes significantly
associated with the affected phenotype. The best was the allelic combination ‘1111’, corresponding
to a risk haplotype with frequencies of 62% in the cases and 56% in the controls, and a value of





Using  the high quality  filtered genome‐wide data  from  the European and African American 
genome‐wide association  scans, we performed a univariate genetic  logistic  regression association 
analysis of BANK1 using an additive model. In Europeans, 1133 imputed markers mapped on BANK1 




Table  1  and  Supplemental  Table  S1A).  The  best  hit  for  association  was  the  SNP  rs10028805, 
(haplotypic block two, and linkage disequilibrium group five), with OR = 0.8177, confidence interval 
(CI) = 95% (0.7656, 0.8735), and a Pcorr = 2.22E−09 (Figure 2a, Table 1, and Supplemental Table S1A). 
Conditioning  on  rs10028805,  the  association  disappeared,  except  that  of  the  five  low  frequency 
variants  (MAF  <  5%),  rs148572654,  rs10212686,  rs62321740,  4:102857352:AT:ATT,  and 
4:102945562:GT:G  (Table  1  and  Figure  2b),  representing  linkage  groups  8,  11,  12,  16,  and  19, 
respectively. Only by conditioning on rs10028805 and three of these low frequency variants, namely, 
rs148572654,  rs62321740,  and  4:102945562:GT:G,  did  all  of  the  signals  of  association  in  BANK1 
disappear  (Table  1,  Supplemental  Table  S1A,  and  Figure  2c).  In  addition,  these  four  markers 








Figure 1. Haplotypic architecture of the European (EUR) ankyrin repeats 1 (BANK1) gene. Plot
representing pairwise r2 values. Eighteen tagging markers captured all 307 (100%) alleles at r2 ≥ 0.8,
representing their 18 respective linkage disequilibrium groups. These 18 markers are organized in four
haplotypic blocks. The calculation of haplotypic blocks was made using D’.









Figure 2. Plot of 307 markers with association p value < 0.05  in  the EUR sample.  (a) Case–control 
association  analysis  result.  (b)  Case–control  association  analysis  conditioning  on  the  best‐hit 
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Figure 2. Plot of 307 markers with association p value < 0.05 in the EUR sample. (a) Case–control
association analysis result. (b) Case–control association analysis conditioning on the best-hit rs10088205.
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Table 1. Eighteen ankyrin repeats 1 (BANK1) tagging markers with an association p value lower than 0.05, representing their respective linkage disequilibrium groups
in the European (EUR) sample. (p *—p value conditioning on rs10028805; p **—p value conditioning on rs10028805, rs148572654, rs62321740, and 4:102945562:GT:G;
A*—represents the allele used in the association analysis; HP.BK—haplotypic block; LK.GR—linkage disequilibrium group).
HP.BK LK.GR CHR MK.ID BP A1 A2 A* F.ALL F.CAS F.CTR NMISS OR L95 U95 p p * p **
1 1 4 rs4518254 102714254 G T 1 0.42 0.3913 0.4468 8059 0.8256 0.7738 0.8807 6.36E−09 5.52E−02 4.81E−01
1 2 4 rs72602430 102715998 T TG 1 0.1040 0.1000 0.1081 8111 0.8968 0.8079 0.9956 4.10E−02 3.66E−01 8.95E−01
1 3 4 rs36128945 102719913 A C 2 0.3051 0.2831 0.3279 8229 0.8541 0.7970 0.9153 7.88E−06 6.06E−01 9.88E−01
1 4 4 rs28496978 102735437 T A 2 0.0650 0.0641 0.0659 7891 0.8760 0.7679 0.9993 4.88E−02 8.82E−01 5.99E−01
2 5 4 rs10028805 102737250 G A 2 0.3631 0.3384 0.3887 8277 0.8177 0.7656 0.8735 2.22E−09 NA NA
2 6 4 rs2080820 102758403 C A 2 0.2907 0.2668 0.3153 8240 0.8268 0.7709 0.8867 9.87E−08 6.00E−01 8.16E−01
# 7 4 rs17031708 102764358 G A 2 0.1307 0.1209 0.1409 8259 0.8724 0.7933 0.9594 4.89E−03 4.88E−02 1.45E−01
3 8 4 rs148572654 102764832 G T 2 0.0195 0.0161 0.0231 8114 0.7551 0.5968 0.9555 1.93E−02 4.08E−03 NA
3 9 4 rs6857428 102792611 T G 2 0.4496 0.4265 0.4737 8239 0.8442 0.7925 0.8992 1.43E−07 1.84E−01 4.71E−01
3 10 4 rs11939568 102810162 A G 2 0.3278 0.3094 0.3469 8235 0.8805 0.8233 0.9417 2.04E−04 8.33E−01 7.82E−01
3 11 4 rs10212686 102822654 A G 1 0.0473 0.0439 0.0508 8183 0.8474 0.7286 0.9856 3.17E−02 3.50E−02 7.42E−01
4 12 4 rs62321740 102824467 A G 2 0.0339 0.0301 0.0378 8050 0.8172 0.6831 0.9777 2.73E−02 2.62E−03 NA
4 13 4 rs4295265 102835645 C T 2 0.3179 0.3000 0.3363 8052 0.9009 0.8414 0.9645 2.73E−03 9.34E−01 9.83E−01
4 14 4 rs4099101 102847428 A G 1 0.1251 0.1203 0.1301 8244 0.8790 0.7985 0.9677 8.57E−03 3.03E−01 8.05E−01
4 15 4 rs33973573 102855806 G A 2 0.4645 0.4812 0.4472 8210 1.1180 1.0490 1.1910 5.75E−04 9.17E−01 3.50E−01
4 16 4 4:102857352:AT:ATT 102857352 AT ATT 2 0.0312 0.0274 0.0351 8080 0.7753 0.6447 0.9324 6.85E−03 1.96E−03 1.87E−01
4 17 4 rs2851336 102857563 C T 2 0.4128 0.4000 0.4261 8120 0.9355 0.8768 0.9982 4.40E−02 5.58E−01 4.58E−01
4 18 4 4:102945562:GT:G 102945562 GT G 2 0.0109 0.0082 0.0137 8181 0.5969 0.4351 0.8187 1.37E−03 9.43E−03 NA
Table 2. Haplotype rs10028805|rs148572654|rs62321740|4:102945562:GT:G association analysis in the EUR sample.
HAPLOTYPE F.CAS F.CTR F.ALL p
1111 0.6212 0.5605 0.5830 3.89E−13
2111 0.3335 0.3810 0.3520 7.64E−08
1121 0.0297 0.0372 0.0340 3.31E−02
1211 0.0155 0.0213 0.0180 5.07E−02
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In African Americans, 1752 imputed SNPs were mapped on BANK1, of which 260 showed
association test p values lower than 0.05 (Supplemental Table S1B and Supplemental Figure S1B).
Running the tagger tool, a set of 50 markers captured all 260 (100%) alleles at r2 ≥0.8, representing their
50 respective linkage disequilibrium groups (Table 3 and Supplemental Table S1B). These 50 tagging
markers were organized in 8 haplotypic blocks and 11 independent signals (Figure 4). The best hit was
the SNP rs17200824 with OR = 0.6787, CI = 95% (0.5947, 0.7747), and a Pcorr = 9.24E−09. This best-hit
was in linkage group 13, the same as the branch-point site SNP rs17266594 and rs10516487 (R61H)
(Figure 5a, Table 3, and Supplemental Table S1B). After conditioning on rs17200824, the association
signals remained in 11 of the tagging markers (Figure 5b, Table 3, and Supplemental Table S1B).
Only after the conditioning on rs17200824 on two of these 11 variants, rs4295265 and rs149302668,
had all of the signals on the BANK1 association disappeared (Table 3, Supplemental Table S1B and
Figure 5c). In addition, these two markers constituted haplotypes that are significantly associated with
the affected phenotype; the best was the allelic combination ‘11’, corresponding to a risk haplotype
with frequencies of 90% in the cases and 84.6% in the controls, and a value of Pcorr = 3.17E−08 (Table 4
and Figure 3b). It is noted that rs4295265 (Pcorr = 3.89E–07) was located on intron seven, at 2,319 bp
upstream to the exonic SNP rs3733197 (A 353 T, in the ankyrin domain) (Pcorr = 1.44E−07), described
as being associated to SLE1 and sharing the same haplotypic block eight (pairwise r2 = 0.75). The SNP
rs149302668, located on intron 11, was a low frequency variant (MAF = 0.01348).
In EUR, markers significantly associated with SLE were located to haplotypic blocks one and two,
including intron one and intron two–exon two–intron three. In the first haplotypic block, covering
intron one, the markers were organized in linkage disequilibrium groups one, two, and three. Group
one showed the best signal of association in the block with rs4518254 (Pcorr = 6.36E–09) as a best
hit. The second haplotypic block included two linkage disequilibrium groups, five and six, covering
intron two–exon two–intron three. Group five contained rs10028805 (intron2) (Pcorr = 2.22E–09) and
rs10516486 (L98L, exon2). For group six, rs13106926 (intron2) (Pcorr = 1.36E–08) was the best hit;
this group also contained the branch-point site, SNP rs17266594 (intron1), and rs10516487 (R61H, exon
two) [1].
After conditioning on the best-hit, rs10028805, all of the signals of association for the common variation
(MAF > 5%) in BANK1 disappeared; hence, rs10028805 would be the statistically most plausible causal SNP
of the BANK1 association to SLE in the EUR sample, as previously suggested. It has been remarked that,
as a result of the LD status among the markers in ‘block two–group five’ (intraBK = 0.96) (Supplemental
Figure S2B), we would expect a similar effect with all of them. We observed that from the conditioning on
each of the three SNPs, rs10028805, rs13136297, and rs4411998, the same results were obtained, (=0.99).
However, traces of association with a low-frequency variation remained (Table 1, Supplemental Table S1A,
and Figure 2b). Only after the conditioning on rs10028805 and three low frequency variants, rs148572654,
rs62321740, and 4:102945562:GT:G, did the signals of association in the BANK1 completely disappear
(Table 1, Supplemental Table S1A, and Figure 2c).
In AA, the markers that were significantly associated (10−8) were located in the same regions as in
EUR, intron one, and intron two–exon two–intron three (Table 2 and Supplemental Table S1B). Intron
one was split in two haplotypic blocks, one and two. In the second block, markers were distributed
in four linkage disequilibrium groups (one, two, three, and four) and the best hits were in the third
group (equivalent to EUR ‘block one–group three′), SNP rs4699262 (Pcorr = 3.19E–08). Region intron
two–exon two–intron three was divided into three haplotypic blocks (three, four, and five) containing
12 linkage disequilibrium groups (Supplemental Table S1B). The best hits were in the fourth haplotypic
block, group 13 (partially equivalent to EUR group six), with the best-hit rs17200824 (Pcorr = 9.24E–09)
and the branch-point site SNP rs17266594 (intron one) and rs10516487 (R61H, exon two).







Figure 4. Haplotypic architecture of BANK1 in AA. Plot representing pairwise r2 values. Fifty tagging markers captured all 260 (100%) alleles at r2 ≥ 0.8, representing
their 50 respective linkage groups in the AA sample. These 50 markers were organized in 8 haplotypic blocks and 11 independent signals. Calculation of haplotypic
blocks was made using D’.
Int. J. Mol. Sci. 2018, 19, 2331 8 of 20
Table 3. Fifty BANK1 tagging markers with association p value lower than 0.05, representing their respective linkage disequilibrium groups in the AA (African
American) sample. (p *—p value conditioning on rs17200824; p **—p value conditioning on rs17200824, rs4295265, and rs149302668; A*—represents the allele used in
the association analysis; HP.BK—haplotypic block; LK.GR—linkage disequilibrium group).
HP.BK LK.GR CHR MK.ID BP A1 A2 A* F.ALL F.CAS F.CTR NMISS OR L95 U95 p p * p **
# 1 4 rs10031210 102714886 A G 1 0.2233 0.2010 0.2479 2529 0.7563 0.6609 0.8655 4.92E−05 1.37E−01 7.25E−01
1 2 4 rs4699262 102726005 G A 2 0.1316 0.1090 0.1613 2520 0.6232 0.5271 0.7369 3.19E−08 1.36E−02 2.11E−01
1 3 4 rs35828857 102729253 A AT 2 0.1633 0.1393 0.1950 2465 0.6727 0.5774 0.7836 3.58E−07 3.52E−02 3.74E−01
# 4 4 rs66638185 102729417 T C 2 0.1658 0.1388 0.1974 2483 0.6574 0.5654 0.7643 4.92E−08 1.32E−02 3.26E−01
2 5 4 rs13136796 102736743 A T 2 0.3177 0.2929 0.3459 2494 0.7764 0.6883 0.8757 3.78E−05 4.88E−01 3.36E−01
2 6 4 rs4615176 102737936 C G 1 0.2351 0.2466 0.2205 2448 1.1790 1.0290 1.3510 1.81E−02 5.38E−01 3.50E−01
2 7 4 rs1421627 102739536 G A 2 0.4148 0.3953 0.4393 2529 0.8230 0.7345 0.9221 7.84E−04 6.58E−01 6.26E−01
2 8 4 rs13136219 102743687 C T 1 0.3893 0.4098 0.3623 2466 1.2320 1.0960 1.3850 4.70E−04 2.67E−01 2.10E−01
# 9 4 rs13112246 102743811 T C 2 0.4072 0.3826 0.4361 2475 0.8045 0.7179 0.9015 1.81E−04 8.76E−01 9.28E−01
# 10 4 rs56857058 102749300 A AT 1 0.3069 0.3208 0.2837 2515 1.2080 1.0690 1.3650 2.42E−03 3.29E−01 1.21E−01
3 11 4 rs144220121 102750582 G GT 2 0.1755 0.1895 0.1610 2478 1.2010 1.0320 1.3970 1.78E−02 3.04E−01 4.71E−01
3 12 4 rs11938136 102750726 G A 2 0.1027 0.1124 0.0925 2501 1.2240 1.0160 1.4750 3.31E−02 2.74E−01 3.51E−01
3 13 4 rs17200824 102752589 A G 2 0.2281 0.1984 0.2664 2516 0.6787 0.5947 0.7747 9.24E−09 NA NA
3 14 4 rs7438361 102756142 G A 2 0.2143 0.2248 0.2000 2427 1.1570 1.0070 1.3290 3.96E−02 6.79E−01 7.94E−01
# 15 4 rs72923462 102758014 G A 2 0.0677 0.0725 0.0571 2427 1.2680 1.0070 1.5980 4.37E−02 2.21E−01 2.50E−01
# 16 4 rs72923467 102760424 G A 2 0.0810 0.0871 0.0692 2475 1.2780 1.0340 1.5780 2.29E−02 1.65E−01 1.32E−01
4 17 4 rs4607219 102773838 T C 1 0.2475 0.2619 0.2327 2473 1.1820 1.0370 1.3460 1.21E−02 6.01E−02 1.54E−01
4 18 4 rs34166099 102778580 C A 2 0.0427 0.0364 0.0510 2428 0.6751 0.5069 0.8993 7.23E−03 1.87E−01 8.52E−01
4 19 4 rs4426778 102780724 G A 1 0.2772 0.2893 0.2658 2512 1.1400 1.0060 1.2910 3.93E−02 2.07E−01 4.42E−01
4 20 4 rs35201947 102781331 C T 2 0.2026 0.1792 0.2329 2427 0.7211 0.6268 0.8297 4.87E−06 1.83E−01 7.15E−01
4 21 4 rs34814827 102787117 C T 2 0.3850 0.3661 0.4046 2513 0.8499 0.7589 0.9518 4.87E−03 5.13E−01 6.53E−01
4 22 4 rs4493533 102820684 C T 1 0.4461 0.4663 0.4251 2496 1.1790 1.0540 1.3190 3.99E−03 1.67E−01 5.78E−01
4 23 4 rs34612070 102832696 TC T 2 0.1222 0.1014 0.1469 2429 0.6586 0.5543 0.7826 2.07E−06 5.30E−02 5.63E−01
4 24 4 rs4295265 102835645 C T 2 0.1107 0.0897 0.1344 2444 0.6206 0.5161 0.7461 3.89E−07 4.97E−03 NA
5 25 4 rs3733197 102839287 G A 2 0.1827 0.1571 0.2150 2516 0.6762 0.5845 0.7824 1.44E−07 8.90E−03 9.33E−01
5 26 4 rs13119516 102841605 G A 2 0.0295 0.0238 0.0365 2505 0.6088 0.4325 0.8570 4.44E−03 1.96E−01 7.32E−01
5 27 4 rs36073662 102841949 G GA 2 0.3743 0.3584 0.3892 2485 0.8659 0.7716 0.9717 1.44E−02 5.73E−01 4.27E−01
# 28 4 rs59723463 102857343 G GAT 2 0.4205 0.4372 0.3982 2445 1.1740 1.0470 1.3150 5.89E−03 2.33E−01 5.17E−01
# 29 4 rs2851336 102857563 C T 2 0.4564 0.4414 0.4702 2452 0.8779 0.7830 0.9844 2.57E−02 5.68E−01 5.43E−01
6 30 4 rs150123613 102879041 G A 2 0.0114 0.0137 0.0081 2424 1.8240 1.0030 3.3170 4.88E−02 8.45E−02 1.10E−01
6 31 4 rs72916176 102881821 T G 2 0.1235 0.1335 0.1081 2432 1.2560 1.0530 1.4970 1.12E−02 1.06E−01 1.64E−01
6 32 4 rs72929915 102890546 A G 2 0.1616 0.1731 0.1451 2423 1.2110 1.0340 1.4180 1.75E−02 5.19E−02 1.44E−01
6 33 4 rs976654 102898570 A C 2 0.2763 0.2478 0.3088 2502 0.7336 0.6462 0.8328 1.69E−06 6.37E−03 2.29E−01
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Table 3. Cont.
HP.BK LK.GR CHR MK.ID BP A1 A2 A* F.ALL F.CAS F.CTR NMISS OR L95 U95 p p * p **
6 34 4 rs1027013 102904490 G A 2 0.1700 0.1433 0.2018 2526 0.6497 0.5581 0.7564 2.69E−08 6.41E−03 6.95E−01
6 35 4 rs2851318 102915668 A T 1 0.3250 0.3400 0.3107 2446 1.1450 1.0150 1.2920 2.76E−02 1.45E−01 6.21E−01
6 36 4 rs6817137 102918724 G A 2 0.1192 0.1299 0.1061 2496 1.2300 1.0300 1.4690 2.26E−02 1.91E−01 2.83E−01
6 37 4 rs2903274 102919138 T C 2 0.4800 0.4553 0.4940 2500 0.8204 0.7320 0.9195 6.71E−04 1.57E−02 2.34E−01
6 38 4 rs6532981 102927216 T C 2 0.2169 0.2314 0.2005 2470 1.1850 1.0320 1.3600 1.64E−02 8.45E−02 3.02E−01
6 39 4 rs6532982 102927310 A G 2 0.1763 0.1906 0.1593 2529 1.2200 1.0520 1.4150 8.47E−03 5.84E−02 1.72E−01
# 40 4 rs1486571 102938040 A T 1 0.1934 0.1725 0.2168 2415 0.7597 0.6538 0.8827 3.32E−04 4.79E−02 7.27E−01
7 41 4 rs11412036 102942316 G GA 1 0.0763 0.0626 0.0917 2419 0.6614 0.5320 0.8222 1.97E−04 3.86E−02 3.06E−01
7 42 4 rs2850390 102943996 A C 1 0.1462 0.1247 0.1693 2529 0.7007 0.5961 0.8237 1.62E−05 1.85E−02 6.68E−01
7 43 4 rs2631268 102948730 G T 2 0.3030 0.3151 0.2852 2530 1.1470 1.0150 1.2950 2.74E−02 5.63E−02 3.14E−01
7 44 4 rs3133078 102952819 C A 1 0.1673 0.1467 0.1890 2440 0.7383 0.6317 0.8628 1.36E−04 4.67E−02 7.79E−01
7 45 4 rs149302668 102955310 G A 2 0.0135 0.0114 0.0182 2507 0.6105 0.3773 0.9876 4.44E−02 2.91E−02 NA
# 46 4 rs11326096 102968589 CT C 1 0.3067 0.2886 0.3298 2436 0.8334 0.7370 0.9423 3.65E−03 1.92E−01 6.33E−01
8 47 4 rs2850397 102970744 G T 1 0.2362 0.2135 0.2629 2409 0.7759 0.6785 0.8873 2.10E−04 5.74E−02 4.17E−01
8 48 4 rs2658535 102971016 G A 1 0.3901 0.3674 0.4214 2454 0.8118 0.7237 0.9107 3.78E−04 6.30E−02 6.12E−01
8 49 4 rs116552800 102974226 A G 2 0.0386 0.0438 0.0318 2410 1.3840 1.0170 1.8840 3.88E−02 1.23E−01 2.06E−01
# 50 4 rs2129292 102991139 C G 1 0.3598 0.3400 0.3802 2418 0.8531 0.7572 0.9611 9.00E−03 1.03E−01 8.72E−01












Case–control  association  analysis  result  conditioning  on  markers  rs17200824,  rs4295265,  and 
rs149302668. 
Table 4. Haplotype rs4295265|rs149302668 association analysis in the EUR sample. 
HAPLOTYPE  F.CAS  F.CTR  F.ALL  p 
11  0.8999  0.8464  0.8760  3.17E−08 
12  0.0112  0.0179  0.0130  5.21E−02 
21  0.0889  0.1357  0.1110  4.02E−07 
Note that AA group eight, partially equivalent to EUR group six, containing the best‐hits, did 
not  contain associated markers at  the genome‐wide association  study  (GWAS)  level  in AA  (SNP 
rs10028805 had a p value = 4.72E–04) (Supplemental Table S1B), and was independent of group 13 
(AAgroups_8_13 = 0.18 and EURgroups_5_6 = 0.70). 
No marker,  including  the best hit  in  the AA population,  rs17200824, was able  to completely 
eliminate  the  associations  of  all  of  the  others,  (Table  3  and  Supplemental  Table  S1B). Only  by 
conditioning on rs17200824 and two variants, rs4295265 and rs149302668, did all of the signals of the 
association  in  BANK1  disappear  (Table  3,  Supplemental  Table  S1B,  and  Figure  5c).  Note  that 
rs4295265  (Pcorr = 3.89E–07) was  located on  intron seven at 2319 bp upstream  to  the exonic SNP 
rs3733197 (Pcorr = 1.44E–07) (exon seven, A353T ankyrin domain), described as SLE associated one. 
Thus, the elimination of the genetic association in AA required conditioning on the markers located 
Figure 5. Plot of 260 markers with association p values < 0.05 in AA. (a) Case–control association analysis
result. (b) Case–control association analysis result conditioning on best-hit rs17200824. (c) Case–control
association analysis result conditioning on markers rs17200824, rs4295265, and rs149302668.
Table 4. Haplotype rs4295265|rs149302668 association analysis in the EUR sample.
HAPLOTYPE F.CAS F.CTR F.ALL p
11 0.89 0.8464 0.8760 3.17E−08
12 0.0112 0.0179 0.0130 5.21E−02
21 0.0889 0.1357 0.1110 4.02E−07
t t at A group eight, partially equivalent to EUR group six, containing the best-hits, did not
contain associated markers at the genome-wide association study (GWAS) level in AA (SNP rs10028805
had a p value = 4.72E–04) (Supplemental Table S1B), and was independent of grou 13 (AAgroups_8_
= 0.18 and EURgroups_5_6 = 0.70).
, i l i t t it i t l ti , , l t l t l
li i i i ll , l l l l . l
i i i rs17200824 and two variants, rs4295265 and rs149302668, id all of the signals of
the association in BANK1 disappear (Table 3, Supplemental Table S1B, and i re .
. ) l i i
. , i i ), i i t .
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Thus, the elimination of the genetic association in AA required conditioning on the markers located
in at least two separate blocks, suggesting two independent but closely related signals, as well as
suggestive signals in the intron [7].
We then performed a trans-racial ‘EUR–AA’ meta-analysis. We selected 165 markers that showed
association p values less than 0.05 in both of the EUR and AA samples (Supplemental Table S2).
The set of meta-analysis best signals for association were located on the region comprising intron
two, exon two, and intron three. In EUR, it coincided with haplotypic block two containing linkage
disequilibrium groups five and six, while in AA, the same region was divided into three haplotypic
blocks containing seven linkage disequilibrium groups (5, 6, 7, 8, 9 10, and 13). Note that the markers
in the EUR linkage disequilibrium groups five and six, in the AA sample, were divided into groups
of 5, 8, 9, and 10, and 6, 7, and 13 (Table 5, Supplemental Table S2, and Supplemental Figure S3B).
The meta-analysis of the SNP rs10028805 in groups EUR 5 and AA 8 showed OR = 0.8167, CI = 95%
(0.7712, 0.8648), and Pval = 4.33E–12. Interestingly, rs10028805 had a Pval = 4.71 E–04 in the AA sample,
clearly under the accepted GWAS threshold. It should be noted that the linkage disequilibrium group
AA 13 (and EUR 6) contained the rs71597109, best hit of the meta-analysis, OR = 0.7898, CI = 95%
(0.7423, 0.8404), and Pval = 6.86E–14. In addition, SNP rs71597109 shared, with group AA 13, rs17200824
and the markers described as the best causal hits of the BANK1 association to with SLE, such as the
branch-point site SNP rs17266594 on intron two, and the R61H rs10516487 on exon two. We then
performed an eQTL analysis using various sources of data available, [8–11], as described. The analysis
showed that several associated and non-associated SNPs had eQTL effects. In fact, all of the strongly
associated SNPs were eQTLs covering a region from the promoter of BANK1 to UTR-3′/downstream
region. However, the strongest eQTLs, according to the BIOS browser10, were localized to intron
two, close to exon two, exon two, and intron three, correlating with the most associated SLE signals
at the GWAS significance level. These eQTLs were rs13136297 (Cis-eQTL Exon-ratio p = 5.29E–39)
and rs10028805 (Cis-eQTL exon-level p = 2.74E–52), on the European haploblock two, linkage group
five, and the AA haploblock three, linkage group eight. Importantly, risk was associated with an
increased expression of BANK1 (Supplemental Table S3 and Figure 6), and importantly, the effects were
directly observed in the RNA-Seq data at the exon level of the expression. Using the BIOS data, we also
identified a cis-meQTL, specifically rs6833764 containing CpG cg01116491 (p = 3.64E–35), located in
the European haploblock one linkage group one; this SNP is however not associated with SLE in AA
(Supplemental Table S3).
In order to better define the functional effects on the BANK1 gene expression, we performed an
analysis of the ENCODE tracks and investigated the possible causes for the eQTLs. This analysis
revealed that the number of annotations in the BANK1 SNPs increased from the promoter, peaking
in the region of association of SLE, centered in intron two and exon two. Using the meta-analysis
data, these annotations can be observed in the Supplemental Table S4 (see the various sheets for
transcription factor binding site, histones, and junctions). These annotations showed an enrichment of
the splice junctions (p value = 1.98E–08, Fisher’s exact test), and in various histone marks, particularly
histone three lysine 36 27 trimethylation (H3K27me3, p-value = 1.20E–10) (Supplemental Table S4),
in the lymphoblastoid cell line Gm12878, further supporting a clear regulatory BANK1 region in
this area. The activating histone marks, such as H3K4me1, H3K4me3 in peripheral, and cord blood
B cells and CD56+ NK cells, covered the whole associated region. Some spots were also observed
in the monocytes and CD34+ hematopoietic stem cells (HSC), but these were clearly less abundant
across the region. In addition, the best-hits were enriched for the sites of binding of the transcription
factor EZH2 in the Gm12878 cell line (p value = 2.99E–44). One transcription factor binding site for
RUNX3, an activator of the transcription of B cells, was observed in the GM12878 lymphoblastoid cell
line, where SNP rs13106926 is located (Supplemental Table S4) (UCSC genome browser, coordinates
chr4: 102,739,791–102,739,791 of GRCh37/Hg19) (Supplemental Material) 14. This SNP is also found
within an active histone mark, histone 3 lysine 27 acetylation mark (H3K27Ac), according to the
UCSC browser14. This SNP is an eQTL in lymphoblastoid cell lines, according to the Harvard
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browser15, but no records were obtained on the BIOS browser. This SNP is located within the European
haplotypic block two, group six, and the AA block three, group six, and is strongly associated with
SLE (Supplemental Table S2).
Combining all of the information, our data supports the functional effects limited to the regions of
intron two, exon two, and intron three, in both European and African Americans. As expected, the AA
population shows a more dispersed haplotypic structure than Europeans, separating the haplotypic
block two containing linkage disequilibrium groups five and six, into three haplotypic blocks (three,
four, and five) with seven linkage disequilibrium groups (5, 6, 7, 8, 9 10, and 13) (Supplemental Table S2
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Figure  6.  BANK1  gene  regulation  and  systemic  lupus  erythematosus  (SLE)  association  map. 
Functional  map  of  BANK1  locus.  RefSeq  transcripts  are  shown.  The  alternative  exon  is  red‐
highlighted. Functional elements are shown according to ChromHMM segmentation for Roadmap 
Epigenomics project  (B  cells, spleen) and ENCODE  (GM12878  lymphoblastoid cell  line  [LCL]  cell 
line).  Transcribed  areas,  promoter,  and  enhancer marks  are  depicted  as  green,  red,  and  orange 
rectangles, respectively. Fantom5 tissue‐specific transcribed enhancers loci are shown as enhancer 1 
(hg19  chr4:102728165‐102728530)  specific  to  spleen,  blood,  and  B‐lymphocytes;  enhancer  2  (hg19 




Figure 6. BANK1 gene regulation and systemic lupus erythematosus (SLE) association map. Functional
map of BANK1 locus. RefSeq trans ripts are show . The alternative exon is red-highlighted. Functional
elements are show according to ChromHMM segmentati n for Road ap Epigenomics project
(B cells, spleen) and ENCODE (GM12878 lymphoblastoid cell line [LCL] cell line). Transcribed areas,
promoter, and enhancer marks are depicted as green, red, and orange rectangles, respectively. Fantom5
tissue-specific transcribed enhancers loci are shown as enhancer 1 (hg19 chr4:102728165-102728530)
specific to spleen, blood, and B-lymphocytes; enhancer 2 (hg19 chr4:102894116-102894225) specific
to lymph node, esophagus, B-lymphocytes, melanocytes, and basophils. Shown below is the SLE
association plot for European data and expression quantitative trait locus (eQTL) map for BANK1 gene
in blood (top markers shown for exon-ratio and exon-level eQTL, according to BIOS [whole blood
data] and to MuTHER [LCL data]).
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Table 5. The EUR–African Americans’ (AA) meta-analysis best signals for association located on the region comprising intron two, exon two, and intron three. In the
EUR, the association best-hit coincided with haplotypic block two, containing linkage disequilibrium groups five and six; the AA the region was divided into three




A1 A2 A* H.B L.G N F FCAS FCTR Pval A* H.B L.G N F FCAS FCTR Pval OREUR ORAA ORFEM L95FEM U95FEM Pval HetPval
rs13136796 102736743 I2 A T 2 2 6 8227 0.2874 0.2634 0.3123 7.36E−08 2 3 6 2494 0.3177 0.2929 0.3459 3.78E−05 0.8244 0.7764 0.8119 0.7641 0.8627 2.05E−11 0.31
rs66976837 102736943 I2 CTTGTT C 2 2 6 8228 0.2874 0.2633 0.3124 6.66E−08 2 3 6 2495 0.3176 0.2929 0.3455 4.13E−05 0.8239 0.7774 0.8118 0.7640 0.8626 1.97E−11 0.32
rs10028805 102737250 I2 G A 2 2 5 8277 0.3631 0.3384 0.3887 2.22E−09 1 3 8 2528 0.3930 0.4139 0.3665 4.72E−04 0.8177 0.8137 0.8167 0.7712 0.8648 4.33E−12 0.87
rs4615176 102737936 I2 C G 2 2 5 8190 0.3699 0.3452 0.3955 2.33E−09 1 3 5 2448 0.2351 0.2466 0.2205 1.81E−02 0.8177 0.8482 0.8234 0.7759 0.8738 1.83E−10 0.43
rs4411998 102738147 I2 T C 2 2 5 8213 0.3639 0.3395 0.3892 3.77E−09 1 3 8 2502 0.4029 0.4237 0.3763 6.26E−04 0.8198 0.8177 0.8193 0.7736 0.8677 9.57E−12 0.88
rs2052445 102738722 I2 A G 2 2 6 8232 0.2877 0.2636 0.3126 7.45E−08 2 3 6 2495 0.3175 0.2926 0.3454 4.19E−05 0.8245 0.7777 0.8123 0.7645 0.8631 2.25E−11 0.32
rs5860695 102738856 I2 TA T 2 2 6 8203 0.2882 0.2641 0.3132 7.84E−08 2 3 6 2495 0.3175 0.2926 0.3454 4.19E−05 0.8246 0.7777 0.8124 0.7645 0.8633 2.37E−11 0.32
rs35388091 102739452 I2 C T 2 2 6 8255 0.2890 0.2648 0.3140 5.36E−08 2 3 7 2505 0.4146 0.3946 0.4381 9.61E−04 0.8229 0.8254 0.8236 0.7758 0.8743 2.06E−10 0.79
rs1421627 102739536 I2 G A 2 2 6 8272 0.2899 0.2663 0.3143 9.40E−08 2 3 7 2529 0.4148 0.3953 0.4393 7.84E−04 0.8138 0.8230 0.8164 0.7686 0.8671 4.24E−11 0.88
rs13106926 102739791 I2 A G 2 2 6 8070 0.2900 0.2654 0.3169 1.36E−08 2 3 6 2499 0.3180 0.2931 0.3458 4.12E−05 0.8243 0.7775 0.8121 0.7643 0.8629 2.14E−11 0.32
rs13107572 102739928 I2 C A 2 2 6 8240 0.2879 0.2638 0.3127 7.19E−08 2 3 6 2498 0.3179 0.2929 0.3458 3.94E−05 0.8243 0.7770 0.8120 0.7642 0.8628 2.07E−11 0.32
rs13107612 102739980 I2 C T 2 2 6 8240 0.2879 0.2638 0.3127 7.19E−08 2 4 6 2492 0.3186 0.2939 0.3461 5.06E−05 0.8226 0.7798 0.8115 0.7637 0.8623 1.80E−11 0.35
rs71597109 102741002 I2 C T 2 2 6 8231 0.2894 0.2652 0.3144 5.27E−08 2 4 13 2494 0.2266 0.1969 0.2652 1.02E−08 0.8226 0.6786 0.7898 0.7423 0.8404 6.86E−14 0.02
rs13135381 102743353 I2 A G 2 2 6 8211 0.2881 0.2637 0.3133 6.80E−08 2 4 13 2499 0.2267 0.1978 0.2643 2.27E−08 0.8278 0.6847 0.7941 0.7463 0.8450 2.62E−13 0.02
rs13136219 102743687 I2 C T 2 2 5 8187 0.3661 0.3423 0.3909 8.21E−09 1 4 8 2466 0.3893 0.4098 0.3623 4.70E−04 0.8237 0.8117 0.8208 0.7750 0.8693 1.63E−11 0.77
rs55768089 102743698 I2 T A 2 2 6 8212 0.2877 0.2641 0.3122 1.38E−07 2 4 13 2499 0.2267 0.1978 0.2643 2.27E−08 0.8274 0.6847 0.7938 0.7460 0.8447 2.37E−13 0.02
rs13112246 102743811 I2 T C 2 2 5 8163 0.3662 0.3421 0.3912 9.33E−09 2 4 9 2475 0.4072 0.3826 0.4361 1.81E−04 0.8241 0.8045 0.8191 0.7736 0.8672 8.13E−12 0.61
rs13137133 102744092 I2 C T 2 2 5 8205 0.3740 0.3512 0.3977 3.58E−08 1 4 10 2491 0.3050 0.3187 0.2817 2.68E−03 0.8312 0.8285 0.8306 0.7838 0.8802 3.49E−10 0.98
rs1125271 102745985 I2 C T 2 2 6 8213 0.2877 0.2640 0.3122 1.27E−07 2 4 13 2505 0.2219 0.1924 0.2593 1.42E−08 0.8243 0.6794 0.7904 0.7427 0.8412 9.12E−14 0.02
rs4276281 102746780 I2 A C 2 2 5 8252 0.3734 0.3505 0.3969 4.04E−08 1 4 10 2481 0.3020 0.3140 0.2795 9.75E−03 0.8318 0.8496 0.8357 0.7886 0.8856 1.40E−09 0.71
rs7698632 102747265 I2 G C 2 2 5 8224 0.3724 0.3489 0.3968 1.54E−08 1 4 10 2511 0.3065 0.3202 0.2837 2.47E−03 0.8271 0.8278 0.8273 0.7807 0.8766 1.40E−10 0.93
rs12163856 102747927 I2 A G 2 2 5 8159 0.3750 0.3514 0.3994 1.35E−08 1 4 10 2462 0.3538 0.3634 0.3351 1.89E−02 0.8266 0.8681 0.8362 0.7895 0.8856 1.01E−09 0.5
rs56857058 102749300 I2 A AT 2 2 5 8213 0.3764 0.3530 0.4006 1.77E−08 1 4 10 2515 0.3069 0.3208 0.2837 2.42E−03 0.8282 0.8278 0.8281 0.7816 0.8774 1.58E−10 0.94
rs17266594 102750922 I2 T C 2 2 6 8124 0.2863 0.2624 0.3109 1.25E−07 2 4 13 2514 0.2249 0.1962 0.2639 1.26E−08 0.8285 0.6795 0.7936 0.7459 0.8443 1.80E−13 0.01
rs10516487 102751076 E2 G A 2 2 6 8220 0.2864 0.2624 0.3114 7.34E−08 2 4 13 2518 0.2232 0.1936 0.2604 1.41E−08 0.8273 0.6798 0.7929 0.7452 0.8437 1.53E−13 0.02
rs10516486 102751276 E2 T C 2 2 5 8277 0.3761 0.3528 0.4002 1.30E−08 1 4 10 2530 0.3089 0.3218 0.2866 3.47E−03 0.8269 0.8333 0.8283 0.7818 0.8775 1.66E−10 0.85
rs34029191 102752201 I3 A G 2 2 6 8237 0.2912 0.2676 0.3155 1.38E−07 2 4 13 2517 0.2275 0.1981 0.2655 1.22E−08 0.8270 0.6804 0.7924 0.7448 0.8431 1.32E−13 0.02
rs17200824 102752589 I3 A G 2 2 6 8233 0.2887 0.2651 0.3131 1.15E−07 2 4 13 2516 0.2281 0.1984 0.2664 9.24E−09 0.8268 0.6787 0.7919 0.7444 0.8424 9.88E−14 0.01
rs4637409 102753408 I3 A G 2 2 6 7966 0.2809 0.2565 0.3062 1.04E−07 2 4 13 2527 0.2221 0.1937 0.2604 1.12E−08 0.8264 0.6771 0.7917 0.7441 0.8424 1.05E−13 0.02
rs34749007 102754507 I3 G A 2 2 6 8239 0.2889 0.2653 0.3133 1.09E−07 2 4 13 2469 0.2313 0.2033 0.2670 1.05E−07 0.8265 0.6977 0.7961 0.7480 0.8473 6.18E−13 0.04
rs5860696 102755799 I3 CA C 2 2 5 8004 0.3603 0.3351 0.3863 2.52E−09 1 5 8 2422 0.3906 0.4119 0.3643 8.05E−04 0.8165 0.8183 0.8169 0.7709 0.8656 8.07E−12 0.95
rs4643809 102756099 I3 C T 2 2 5 8038 0.3611 0.3362 0.3869 5.03E−09 1 5 8 2409 0.3844 0.4051 0.3574 7.77E−04 0.8202 0.8163 0.8193 0.7732 0.8682 1.56E−11 0.89
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3. Discussion
We identified a set of SNPs in intron one and surrounding exon two, clearly associated with
SLE in the two studied populations, namely European and African Americans. In our current study,
we did not present in vitro functional tests for these SNPs. We carried out a bioinformatics analysis
and showed that all of the strongest associated SNPs are BANK1-associated eQTLs, and associate with
the enrichment of various epigenetic marks known to associate with pre-mRNA co-transcriptional
exon splicing [8,12]. Furthermore, the data supports, in particular regions containing three SNPs
with potential functional properties, rs13136297 (Cis-eQTL exon ratio), rs10028805 (Cis-eQTL exon
level), and rs13106926 (eQTL), the latter located within the RUNX3 TFBS and an active regulatory
element histone mark in a lymphoblastoid cell line. The combined presence of the histone marks
observed, and the enrichment of the splice junctions further support such co-transcriptional splicing
as a mechanism regulating the splicing of exon two of BANK1 involving a higher level of regulation of
the chromatin topography of the locus. This is also supported by the eQTL data obtained from BIOS
browser. These authors analyzed the functionality of exon ratio cis-eQTLs in mRNA splicing, showing
an enrichment of splicing events and a close proximity to the splicing acceptor and donor sites [9].
Recently, it was shown that the SNPs of BANK1, associated with SLE and identified through
targeted sequencing, increased the expression of the SLC39A8 gene in the LPS stimulated CD14+
monocytes. SLC39A8 is a gene located immediately downstream of BANK1. The authors utilized
the GEUVADIS database, based on the expression data in the lymphoblastoid cell lines (LCLs) and
HapMap SNPs [10]. We have used the Zhernakova data [9], based on whole blood RNA sequencing
information from a large number of European individuals, and still, not all of the SNPs have been found
and the complete information is not fully available. The SNP shown by Raj et al. [11] to be strongly
associated with SLE and an eQTL for SLC39A8 is actually a weak eQTL for this gene, and the effect is
probably related to its LD with SNPs in the promoter of SLC39A8. The main eQTL peak for SLC39A8 is
located within the promoter of that gene [9], not BANK1. We have analyzed our data for a putative
association of the SLC39A8 locus and SLE, and did not observe any evidence of this association (data
not shown). It disproves the involvement of SLC39A8 in the SLE pathogenesis, proposed by Raj and
co-authors [11].
Our genetic analysis and the fact that risk was associated with an increased BANK1 expression at
the exon level, supports our original postulate that the increased expression of the exon two coded
domain of BANK1 may be involved in the development of autoimmunity, and that this expression and
the splicing of exon two are epigenetically regulated.
We show the enrichment of given epigenetic marks, such as H3K27me3 and EZH2, in the BANK1
associated SNP region. Furthermore, the presence of such epigenetic marks supports the observation
of the eQTLs in the SLE-associated SNPs, and that the region could function as an alternative promoter.
In fact, this might be the case, as the BANK1 gene has two transcription initiation sites, and the first
description of the gene had missed the first initiation site [2].
We found one SNP lying with five nucleotides within the binding site of RUNX3, a transcriptional
activator. However, this TFBS is only observed in the lymphoblastoid cell lines and not primary B
cells. Importantly, the RUNX3 transcriptional activity is induced during the Epstein–Barr virus (EBV)
infection of B cell immortality, leading to the repression of RUNX1, with both factors considered
as interesting transcriptional regulators of autoimmunity [13–15]. An infection with EBV has been
considered as an environmental trigger of SLE [16,17]. Nevertheless, we do not know if RUNX3 is
induced in lupus B cells or if the modifications in the RUNX3 transcriptional activity have a role in
the BANK1 expression. Thus, the role of the SNP rs13106926 as an eQTL, associated with SLE and
the RUNX3 transcriptional activity in EBV infected cells is plausible, but needs to be experimentally
tested. Another transcription factor with numerous sites across the region, particularly in intron
one, was the histone methyltransferase EZH2, a member of the polycomb repressive complexes
that promote silencing by catalyzing posttranslational modifications of histones. EZH2 catalyzes
the histone three, lysine 27 trimethylation rich in transcriptional start sites of the repressed genes.
Int. J. Mol. Sci. 2018, 19, 2331 15 of 20
This transcription factor has been shown to protect germinal center B cells and impede the mutation
of the activation-induced cytidine deaminase, an enzyme key in the class switch recombination of
the immunoglobulin heavy chain locus [18]. Its role in SLE B cells and the induction of BANK1 is
also not known, but a role for BANK1 in the class switch recombination was recently suggested in the
mouse [6].
Alternative splicing involves various chromatin modifications, including histone modifications [19].
These changes may function as scaffolds or adaptors for the binding proteins that are part of the
splicing machinery. In particular, an important protein is RNA Pol II, in charge of the elongation, which
interacts with histone modifiers to recruit SR proteins [19]. These proteins are particularly efficient during
co-transcriptional splicing events. In addition, the modulation of H3K36me3 or H3K4me3 levels by the
overexpression or downregulation of their respective histone methyltransferases, changes the tissue-specific
alternative splicing pattern in a predictable fashion [20]. Studies have shown that a chromatin adaptor
protein (CHD1) has a chromodomain that specifically recognizes H3K4me3 and interacts with specific
small RNA proteins28, particularly components of the U2 snRNP complexes.
We reported [7] that the protective allele (61H) of the associated coding SNP rs10516487 led to the
formation of a site for the splicing trans-factor Srp40, suppressing splicing of exon two and, hence,
of the FL isoform. Thus, the differences in the expression of the D2 and FL isoforms of BANK1 lie
behind the risk for SLE, and it is feasible that the co-transcriptional regulation of exon two splicing,
combined with the presence of R61, promotes the expression of the FL isoform and enhanced signaling
in susceptible individuals. Our data and our animal work fully support an increase in the FL BANK1
expression, with increased BANK1-dependent toll-like receptor 7/9 signaling. Interestingly, the RNA
splicing events are controlled by the abundance of SR proteins modulated by the signaling pathway
activity, including the pathways controlled by the phosphatidyl-inositol-3 (PI3K) kinase, a key molecule
in B cell signaling [21], which regulates the phosphorylation of the serine of the Srp40 trans-activator
protein. Therefore, the presence of co-transcriptional alternative splicing modifiers supports our
previous data.
4. Materials and Methods
4.1. Sample Collection and Genotyping
We used GWAS data from 5478 individuals of European ancestry, including 4254 SLE patients
and 1224 controls genotyped using the Illumina HumanOmni1_Quad_v1-0_B chip [12]. The U.K.
subjects with SLE in the study were recruited, with the study having obtained ethical approval from
the London Ethics Committee. Individuals were invited into the study and given information sheets as
well as verbal explanations of what the research entailed. For those individuals willing to participate,
informed written consent was obtained. The recruitment in continental Europe and Canada were
subject to local reviews and ethical approval. Copies of the relevant supporting documentation
were sent to the investigators at King’s College at the commencement of the study [12]. In order to
increase the number of controls, data from the European controls that were genotyped on the same
platform were obtained from the dbGaP database (http://www.ncbi.nlm.nih.gov/gap), including the
DCEG Imputation Reference Dataset (phs000396.v1.p1; 1175 individuals), the GENIE UK-ROI Diabetic
Nephropathy GWAS (phs000389.v1.p1; 903 individuals), and the High Density SNP Association
Analysis of Melanoma (phs000187.v1.p1; 1047 individuals). In total, the initial dataset consisted of 4254
SLE patients and 4349 controls. We used a set of individuals with African American (AA) ancestry,
collected from several of the SLEGEN groups and from the Oklahoma Medical Research Foundation,
following ethics committee approval and informed consent [22]. The African American samples
were genotyped with the same Illumina platform HumanOmni1_Quad_v1-0_B chip as the European
individuals (unpublished data).
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4.2. Data Filtering
In order to obtain a quality-controlled working dataset satisfying current state-of-the-art criteria
for the association studies, data filtering was conducted using PLINK v1.07 [23], applying the following
criteria: minimum total call rate per sample of 90% (18 individuals were eliminated), minimum call rate
per marker of 98%, minor allele frequency (MAF) threshold of 0.01%, Hardy–Weinberg Equilibrium
(HWE) p-value at a minimum of 0.0001 for cases, and 0.01 for controls, as well as a final cutoff p value
of 0.00001 for differential missingness in the no-call genotypes between the cases and controls.
4.3. Stratification Analysis
To assess the genetic diversity in the EUR data set, markers (linkage equilibrium r2 < 0.1) with
maximum differences in the allele frequencies between the HapMap subpopulations (CEU, MXC,
YRI, CHB, EUR, AMR, AFR, and ASN) were selected. A first principal component analysis (without
sigma threshold) showed that all of the samples were indeed of European descent. In the next step,
the genetic diversity within the European context was examined using 13,222 markers (r2 < 0.1),
with maximum allele differences between the HapMap European subpopulations CEU and TSI
(north central and southern Europe, respectively). The principal component analysis was performed
with smartpca, EIGENSOFT 4.0 beta package [24]. A set of 60 samples was detected as outliers,
using a sigma_threshold = 6.0. This low number of outliers supports the European homogeneity
of the sample. An association analysis by logistic regression corrected for stratification with the
first 10 principal components resulted in a λGC = 1.05. The cryptic relatedness was assessed using
REAP [25], by removing one individual from each sample pair with a kinship-coefficient greater than
0.055. Using this procedure, 248 samples were removed. The final data set contained 573,370 autosomal
markers from 8277 individuals (4212 cases and 4065 controls).
The final African American data set contained 2899 individuals, 1761 SLE patients, and 1138
controls. This data set was supplied after QC-filtering, and removing the outliers and ‘closely-related’
samples. For each African American sample, coordinates for the four first PCs were provided.
4.4. Statistical Analyses
The allelic association for each marker was tested using the Plink additive logistic regression,
testing for the minor allele, as in the literature [23]. The Tracy–Widom test was used to evaluate the
significance of the principal components. Association tests included the axes of the 10 most significant
principal components as covariates. The dependency of association for the genetic variants with the
lowest p values were systematically examined by conditional testing. Plots were generated using a
modified version of LocusZoom [26]. The haplotypic relations, defined by D’ (four gametes rule),
were computed using Haploview version 4.2 [27]. The haploview tagger tool was used (threshold
r2 ≥ 0.8) to select the minimum set of tagging markers containing the allelic variability of the whole
BANK1 region, defining the linkage disequilibrium groups of the markers. The haplotype analyses
were carried out with Plink, and the phase was confirmed with BEAGLE version 3.3 [28].
The markers within the region of the BANK1 gene were selected for imputation with IMPUTE2 [29]
using GWAS and 1000Genomes data as reference (http://www.1000genomes.org). Prior to that,
the GWAS data set was pre-phased with Shapeit [30], using only the 1000G EUR populations as
reference. For imputation, a restrictive QC-filter was applied (SNP genotyping rate ≥99%, sample
genotyping rate ≥98%) without restriction of the allele frequencies, in order to include rare and
low frequency variants. To ensure a high degree of reliable imputation, a conservative ‘info_value’
threshold of >0.8 for each marker was applied. The same imputation procedure was used with the
AA data set, with the only difference being that the AFR 1000Genomes’ populations were used as
reference in the Shapeit pre-imputation.
A trans-racial ‘EUR–AA’ meta-analysis was implemented using Metal [31] and Plink. The beta
parameter in the logistic regression (natural logarithm of the odds ratio) was used as the effect and
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the sample size in each study was used as the weighting factor. Two criteria for selecting the markers
resulting in the meta-analysis were used, namely: SLE association p value < 0.05 values and the same
direction of the effect in both studies, and heterogeneity-test p value > 0.01.
4.5. eQTL/meQTL Analysis
In order to explore the relationship between SLE and the BANK1 gene expression, we analyzed the
expression quantitative trait loci (eQTLs) from several recent databases for lymphoblastoid cell lines
(LCLs), cells, or tissues obtained from donors of European ancestry [8–10]. MuTHER [32] includes the
gene expression data from fat, skin, and LCLs. The BIOS browser [9] (genenetwork.nl/biosqtlbrowser)
containing RNASeq data from the peripheral blood derived from 2116 Dutch individuals was used
to define the remaining eQTLs of BANK1. This data set provides quantitative gene and exon
expression data various cis-eQTLs and meQTLs, combined with the cell type and context-specific
data. The RTeQTL [33] browser (http://eqtl.rc.fas.harvard.edu) was used to search for information
on rs13106926.
4.6. Annotation Analysis
We used the genome annotation data assembled under the GenomeRunner project [34] to
annotate the set of BANK1 associated SNPs. Genome annotations include the cell type specific
histone modification marks, transcription factor binding sites, splice junction regions, and other
regulation-related tracks from the ENCODE and Roadmap Epigenomics consortia [35,36]. The analysis
was restricted to the cell type-specific regulatory marks, Gm12878, B-cell lymphoblastoid cell line for
the ENCODE data, and the ‘HSC_and_Bcell’ tissue IDs for the Roadmap Epigenomics data. Only the
annotations that overlap with at least one SNP are reported.
The enrichment p values were calculated using Fisher’s exact test, and were adjusted for multiple
testing using the false discovery rate (FDR) method. Briefly, the enriched co-localization of the set of
BANK1 associated SNPs was assessed against the null hypothesis of the random co-localization.
To evaluate the random co-localization, a set of all of the SNPs from the BANK1 region (chr4:
102614068-103075430, the human GRCh37/hg19 genome assembly) was obtained from dbSNP build
138, totaling 8772 ‘background’ SNPs.
5. Conclusions
Our analysis of two populations showed that the eQTL SNPs could extend to various portions
of the gene, but were indeed centered on the same major region of the BANK1 gene, surrounding
exon two. The genetic association of BANK1 in AA individuals is particularly strong and supports
an important role of the B cell-related pathways in the disease in those individuals. The linkage
disequilibrium groups AA 13 and EUR 6 contained, what could be considered the best meta-analysis
hits, the SNP rs71597109 and markers described as the best causal hits of the BANK1 association to SLE,
such as the branch-point site SNP rs17266594 on intron two, and the R61H rs10516487 on exon two.
The presence of at least two independent genetic effects in AA shows that BANK1 contributes to
the inheritance of risk through two separate haplotype blocks containing eQTLs.
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